Synapse - Works

Results (1585)

TTI-622-01: A phase 1a/1b dose-escalation and expansion trial of TTI-622 in patients with advanced hematologic malignancies, including diffuse large B-cell lymphoma (DLBCL)

Meeting Abstract

Patel, K.; Sano, D.; Maris, M.; Lesokhin, A. M.; Von Keudell, G.; Doucette, K.; Ramchandren, R.; Pavlov, D.; Uger, R. A.; Molloy, N.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Immunogenomic characterization of biliary tract cancers: Biomarker enrichment for benefit to immune checkpoint blockade

Meeting Abstract

Park, W.; Keane, F.; Bandlamudi, C.; Donoghue, M.; de Lara, P. T.; Harding, J. J.; Khalil, D.; McKinnell, Z.; Sterpi, M.; Cao, W.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Central nervous system (CNS) outcomes and progression patterns in patients with RET fusion-positive lung cancers treated with selpercatinib

Meeting Abstract

Murciano-Goroff, Y. R.; Falcon, C. J.; Lin, S. T.; Dhawan, A.; Grimaldi, G.; Liu, D.; Wilhelm, C.; Thomas, R.; Iasonos, A.; Drilon, A. E.
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development

Meeting Abstract

Liu, D.; Murciano-Goroff, Y. R.; Jee, J.; Arcila, M. E.; Buonocore, D. J.; Gao, J.; Chakravarty, D.; Schram, A. M.; Callahan, M. K.; Friedman, C. F.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Minimal residual disease (MRD) detection by ctDNA in relation to radiographic disease progression in patients with stage I-III non-small cell lung cancer (NSCLC) treated with definitive radiation therapy

Meeting Abstract

Lebow, E. S.; Murciano-Goroff, Y. R.; Jee, J.; Kalashnikova, E.; Feeney, J.; Sethi, H.; Aleshin, A.; Kris, M. G.; Chaft, J. E.; Rudin, C. M.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma

Meeting Abstract

Kinnaman, M. D.; Zaccaria, S.; Makohon-Moore, A.; Gundem, G.; Ossa, J. E. A.; Bouvier, N.; Dela Cruz, F. S.; Hameed, M.; Bender, J. L. G.; Tap, W. D.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

MERLIN_001: A prospective registry study of a primary melanoma gene-signature to predict sentinel node (SN) status and determine its prognostic value for more accurate staging of patients with SN-negative melanoma

Meeting Abstract

Hieken, T. J.; Egger, M. E.; Angeles, C. V.; Lowe, M. C.; Burke, E. E.; Bartlett, E.; Hyngstrom, J. R.; Sondak, V. K.
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Mechanisms of acquired resistance to TRK inhibitors

Meeting Abstract

Harada, G.; Choudhury, N. J.; Schram, A. M.; Rosen, E.; Murciano-Goroff, Y. R.; Falcon, C. J.; Wilhelm, C.; Kaplanis, L. A.; Liu, D.; Chang, J. C.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Disparities in speed to BMT consult and allograft in 279 adults with AML

Meeting Abstract

Fingrut, W. B.; Gyurkocza, B.; Davis, E.; Flynn, J.; Scaradavou, A.; Chinapen, S.; Naputo, K.; Quach, S.; Cho, C.; Giralt, S.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Clinical efficacy of daratumumab (DARA)-based second line therapy after DARAcontaining and DARA-free induction therapies in multiple myeloma: A single center experience

Meeting Abstract

Ciardiello, A.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Lu, S. X.; Patel, D.; Maclachlan, K.; Lahoud, O. B.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save